Npm1 Aml (updated 2024-12-12)

NPM1 mutated AML [upl. by Morven]

NPM1 mutated AML

Duration: 5:40
7 views | 3 months ago

joint IACRLRDIACH webinar Targeted diagnosis and therapy of NPM1mutated AML [upl. by Dorcy]

joint IACRLRDIACH webinar Targeted diagnosis and therapy of NPM1mutated AML

Duration: 1:14:18
199 views | 4 months ago

NPM1 mutated Acute Myeloid Leukaemia [upl. by Hillari]

NPM1 mutated Acute Myeloid Leukaemia

Duration: 3:08
174 views | 5 months ago

FRCPath Morphology and Viva practice Meeting 2 Recording [upl. by Gnolb]

FRCPath Morphology and Viva practice Meeting 2 Recording

Duration: 1:19:28
394 views | 4 months ago

What were your highlights from ASH 2023 [upl. by Aniretak]

What were your highlights from ASH 2023

Duration: 3:42
128 views | 9 months ago

The NEXT platform drug sensitivity screening for AML [upl. by Macknair608]

The NEXT platform drug sensitivity screening for AML

Duration: 3:34
96 views | 7 Dec 2020

Understanding the molecular complexity of AML [upl. by Maxama]

Understanding the molecular complexity of AML

Duration: 2:17
108 views | 29 Jun 2023

Minimal Residual Disease in NPM1 mutated AML [upl. by Hendrickson]

Minimal Residual Disease in NPM1 mutated AML

Duration: 13:30
187 views | 28 May 2018

The emerging role of menin inhibitors in the treatment of NPM1mutated and KMT2Arearranged RR AML [upl. by Notyalk]

The emerging role of menin inhibitors in the treatment of NPM1mutated and KMT2Arearranged RR AML

Duration: 1:41
442 views | 17 Jan 2023

Sosialisasi Time amp Ennergy Management RUBY EDISI 2024 [upl. by Hayyifas]

Sosialisasi Time amp Ennergy Management RUBY EDISI 2024

Duration: 22:14
19 views | 2 months ago

The Advantage of Innovation in AML [upl. by Syck]

The Advantage of Innovation in AML

Duration: 1:33:16
585 views | 12 Jul 2022

Maintenance venetoclax and 5azacytidine in patients with AML [upl. by Dardani]

Maintenance venetoclax and 5azacytidine in patients with AML

Duration: 2:37
353 views | 12 Dec 2021

ASH Clinical News May 2024 From the Desk Of [upl. by Erminna232]

ASH Clinical News May 2024 From the Desk Of

Duration: 3:31
193 views | 7 months ago

Phase I study of ziftomenib with venetoclax or venetoclaxazacitidine or 73 in RR AML [upl. by Etnoed701]

Phase I study of ziftomenib with venetoclax or venetoclaxazacitidine or 73 in RR AML

Duration: 1:12
92 views | 12 Jun 2023

Improving the activity of BH3 mimetic venetoclax a case study [upl. by Koran]

Improving the activity of BH3 mimetic venetoclax a case study

Duration: 2:49
128 views | 11 Jun 2018

Menin Inhibitors are on the Horizon for NPM1 Mutated AML Eytan Stein ASH 2021 AML [upl. by Acinorehs21]

Menin Inhibitors are on the Horizon for NPM1 Mutated AML Eytan Stein ASH 2021 AML

Duration: 2:24
425 views | 13 Dec 2021

Promising novel agents in AML menin inhibitors [upl. by Aliakim]

Promising novel agents in AML menin inhibitors

Duration: 1:14
172 views | 7 months ago

JOGJA ISTIMEWA 2024 kel J kel 10 [upl. by Merla905]

JOGJA ISTIMEWA 2024 kel J kel 10

Duration: 4:26
12 views | 2 months ago

AML with NPM1 mutation [upl. by Vivia]

AML with NPM1 mutation

Duration: 9:58
246 views | 2 Mar 2023

Bringing precision medicine and MRD into clinical strategies [upl. by Sidnee]

Bringing precision medicine and MRD into clinical strategies

Duration: 1:49
63 views | 1 Jul 2020

34 Postinduction MRD identifies patients with NPM1 AML who benefit from allogeneic transplant [upl. by Hercules]

34 Postinduction MRD identifies patients with NPM1 AML who benefit from allogeneic transplant

Duration: 28:41
36 views | 4 months ago

Kelompok 2 Tugas Wawancara Mata Kuliah jurnalistik Penggunaan AI Dalam Pembuatan Berita [upl. by Tamarra216]

Kelompok 2 Tugas Wawancara Mata Kuliah jurnalistik Penggunaan AI Dalam Pembuatan Berita

Duration: 23:58
11 views | 1 week ago

Lorenzo Brunetti [upl. by Adolphus]

Lorenzo Brunetti

Duration: 0:54
320 views | 16 Dec 2022

Genomic characterization of newly diagnosed AML in patients over the age of 60 [upl. by Arracat]

Genomic characterization of newly diagnosed AML in patients over the age of 60

Duration: 1:55
47 views | 11 months ago

Prognostic significance of molecular MRD in NPM1mutated AML treated with venetoclaxbased therapy [upl. by Nyrret]

Prognostic significance of molecular MRD in NPM1mutated AML treated with venetoclaxbased therapy

Duration: 2:03
126 views | 1 year ago

Classification of Acute Myeloid leukemia according to World health Organization [upl. by Netsuj]

Classification of Acute Myeloid leukemia according to World health Organization

Duration: 7:11
33 views | 6 months ago

Personalizing AML treatment by targeting MRD mutations [upl. by Sobmalarah280]

Personalizing AML treatment by targeting MRD mutations

Duration: 1:03
100 views | 10 months ago

Unlocking Myeloid Malignancies Genetic Insights [upl. by Inglis]

Unlocking Myeloid Malignancies Genetic Insights

Duration: 0:44
1 views | 2 weeks ago

AML ALL CML CLL Buzzwords TO GET YOU POINTS [upl. by Yeliak]

AML ALL CML CLL Buzzwords TO GET YOU POINTS

Duration: 5:07
53.7K views | 10 Jun 2013

Identifying low and highrisk AML [upl. by Llerreg]

Identifying low and highrisk AML

Duration: 3:16
862 views | 6 Dec 2021

New on site

Content Report
youtor.org / Youtor Videos converter © 2024